UK Testing Guide — Pharmacogenomics and Endocrine Panel

Two major gaps in Anthony's investigation: (1) pharmacogenomics to optimise medication and supplements, and (2) endocrine screening to rule out hormonal contributors to fatigue. This guide compares UK-available tests by value, coverage, and relevance.


Panel 1: Pharmacogenomics

Why Test

Question Gene(s) Impact if Variant Found
Is your folate form correct? MTHFR C677T, A1298C Switch folic acid → methylfolate
How do you metabolise Elvanse? CYP2D6, CYP2B6 Dose adjustment; explains unusual response
Stress sensitivity + dopamine clearance? COMT Val158Met Guides stimulant response expectations
Supplement/medication interactions? CYP1A2, CYP2C19, CYP3A4 Caffeine metabolism, future medication choices

Best-Value Options (March 2026)

Option A: myDNA via Healthily — £170

Option B: FGIH Pharmacogenomics — £299

Option C: Body Fabulous Methylation Test — £289–£520

Best value combo: Option A + Option C (lab results only) = £170 + £289 = £459

This covers both axes:

Budget option: Option A alone (£170) — gets the Elvanse-specific pharmacogenomics. Then request MTHFR from GP (NHS will sometimes test if you have a clinical reason — folate supplementation + neurodevelopmental conditions is reasonable).

Alternative: Existing 23andMe/AncestryDNA data — If Anthony has ever done a consumer DNA test, raw data can be uploaded to services like Gene2Rx for pharmacogenomic interpretation, or Genetic Genie for MTHFR/COMT methylation analysis at minimal cost (often free or <£20).


Panel 2: Endocrine / Hormonal Screen

Why Test

Iron overload deposits in endocrine organs. At ferritin 380 (previously 700) and TSAT 60%, these axes are at risk:

Axis Iron Risk Symptom Overlap with AuDHD
Testosterone Iron deposits in pituitary + testes → hypogonadism Fatigue, low motivation, brain fog, mood
Thyroid Iron impairs T4→T3 conversion Fatigue, cognitive sluggishness, cold intolerance
Insulin/glucose Iron damages pancreatic beta cells Energy crashes, metabolic risk
Vitamin D Already flagged as untested; modulates hepcidin Fatigue, TTM (OR 4.2), mood, bone health
Cortisol HPA axis dysregulation from chronic stress/burnout Fatigue, sleep disruption, inflammation

Best-Value Options (March 2026)

Option A: Medichecks Advanced Thyroid Function — £89

Option B: Medichecks Male Hormone Check — £79

Option C: Medichecks Diabetes (HbA1c) — £46

Best value combo: Options A + B + C = £89 + £79 + £46 = £214

Do them on the same venous draw at a Medichecks partner clinic (+£35 once) = £249 total for:

That's 21 biomarkers for £249 covering all endocrine gaps.

Budget option: Option A alone (£89) — thyroid + vitamin D + inflammation. Most bang for buck if choosing one.

NHS route: Ask GP to add testosterone, thyroid, HbA1c, and vitamin D to the next iron monitoring bloods. Frame it as: "Iron overload can affect the pituitary and thyroid — can we check these alongside my next ferritin/TSAT?" Most GPs will agree given your HFE diagnosis.


Combined Testing Plan — Summary

Test Provider Price What It Answers
myDNA Pharmacogenomics Healthily £170 Elvanse metabolism, future medication guidance
Methylation panel Body Fabulous £289 MTHFR, COMT, folate form
Endocrine panel (thyroid+hormones+HbA1c) Medichecks x3 £249 Testosterone, thyroid, vitamin D, HbA1c, CRP
Total £708 Covers all major gaps

Updated after December 2025 results (thyroid, HbA1c, B12 all normal):

Prioritised if budget is limited:

  1. MTHFR/methylation test — now HIGHEST priority. Dec 2025 shows folate 6.8 nmol/L (LOW) despite folic acid supplementation. Body Fabulous (£289) or cheaper MTHFR-only test
  2. Medichecks Male Hormone Check (£79) + Vitamin D (~£39) = £118 + £35 venous = £153 — testosterone is the only untested endocrine axis; vitamin D still untested
  3. myDNA pharmacogenomics (£170) — directly relevant to current medication
  4. Medichecks thyroid/HbA1cno longer needed, Dec 2025 results normal

What to Do With Results

Finding Action
Low testosterone Discuss with GP — may improve dramatically with phlebotomy; if not, testosterone replacement
Abnormal thyroid (low T3, high TSH) GP referral for thyroid management; iron reduction may help
HbA1c ≥42 mmol/mol (pre-diabetic) Dietary intervention + phlebotomy (iron reduction improves insulin sensitivity)
Vitamin D deficient (<50 nmol/L) Start D3 2000–4000 IU/day + K2; retest at 3 months
Elevated hs-CRP Confirms systemic inflammation → supports IDO/kynurenine hypothesis → prioritise anti-inflammatory interventions
MTHFR C677T homozygous Switch to methylfolate immediately
COMT Val/Val (fast COMT) Lower dopamine baseline → may benefit from higher-dose stimulant; less stress-resilient
CYP2D6 poor/rapid metaboliser Elvanse dose may need adjustment; affects future medication choices

Cross-References